Extract notice to the Minister
Ilumya (psoriasis en plaques)
Common name / Subject : tildrakizumab
Name of the manufacturer : Sun Pharma
Form : Sol. Inj. S.C. (stylo)
Dosage : 100 mg/ml (1 ml)
Name of the manufacturer : Sun Pharma
Form : Sol. Inj. S.C. (stylo)
Dosage : 100 mg/ml (1 ml)
Indication : Psoriasis en plaques
INESSS' Recommendation
Inscription - Sous conditions
Minister's decisions
Inscription sur les listes des médicaments, Médicament d'exception (2026-03-04)
Evaluation published on February 18, 2026
INESSSid: 28245
Recevable on September 02, 2025